Zichor Life Tech

ABOUT US

Our Foundation

BUILT TO LAST & HERE TO STAY

Established in 2023

VISION

“Saving lives through advanced and reliable medical solutions”

Founded by a team of experienced Doctors

Dr. Chaitanya, Dr. Swetha & Dr. Sathya the company is built on deep clinical expertise and a strong understanding of real-world surgical needs.

“Built for speed, compliance, and clinical impact, Zichor combines manufacturing excellence with surgeon-first innovation. Our mission is simple: deliver high-performance surgical products that compete globally—without compromise on quality, safety, or accessibility.”

Department Contacts

MEET THE TEAM

Dr. Chaithanya

Managing Director

Dr. Sathyanarayana

Director & CEO

Dr. Swetha

Director & CFO

Rashmi Nair

Chief International Business Officer

S M Narayan

Head of HR

Jayanth Birari

Head of Operation

Raghvendra

Head of Quality

Praveen B

Head of Supply Chain

Arun Kumar

Head of Accounts

Rupesh Shimpi

UI UX & Graphic Designer

INFRASTRUCTURE

Core Capability

PRECISION AT SCALE

Total Campus

3,50,000 sq. ft

Built Up

25,000 sq. ft

Clean Room

8,000 sq. ft

Class 10,000 (ISO Class 7)

Ensuring strict sterility and biocompatibility essential for medical device manufacturing.

Our facility is equipped with advanced machinery, in-house laboratory and instrumentation setups, and dedicated R&D units. A team of highly skilled and competent professionals ensures precision, consistency, and uncompromised quality in every product we manufacture.​​

01

100% Clean-Room Manufacturing

02

Analytical Laboratories

03

Inhouse R&D

04

Strong Regulatory Backing

ISO

ISO 13485 Compliant QMS

Our quality management system is built to ISO 13485 the gold standard for medical device quality assurance globally

GMP

Manufacturing Standard

All manufacturing processes adhere to Good Manufacturing Practice guidelines as defined by international regulatory authorities

Compliance

100% Regulatory Compliant

We ensure the facility is compliant with all the regulatory requirements to the highest standard

RESEARCH & DEVELOPMENT 

Pipeline

structured phase-gated development

  1. In- vitro proof-of-concept through pre-clinical animal models
  2. Clinical validation in human surgical cases.
Our development process is physician-led at every stage from identifying unmet clinical need through designing study endpoints that reflect what actually matters to a surgeon at the table under pressure.

We collaborate with leading academic medical centers, hemostasis research laboratories, and clinical investigators across India and globally to ensure our science is both cutting-edge and clinically relevant.

Research Foundation

SCIENCE FIRST

No Zichor product reaches commercialization without rigorous, independent evidence of safety and efficacy.

Coagulation-Independent Hemostasis

Developing active hemostatic agents that achieve rapid clot formation independently of the patient's own coagulation cascade enabling effective bleeding control in anticoagulated, thrombocytopenic, and coagulopathic patients.

Topical Bioadhesive Hemostats

Engineering next-generation tissue-adhesive hemostatic dressings with superior wet-surface adhesion, biodegradability, and zero foreign-body reaction for both open and laparoscopic applications.

CERTIFICATION

Certification is not a checkbox it is the foundation of our promise to patients, clinicians, and healthcare systems. We pursue the most rigorous international regulatory standards as a reflection of our commitment to safety and quality.

Our Standards

CERTIFIED TO THE HIGHEST STANDARD

Our certifications span manufacturing quality, product performance, biocompatibility, and sterility covering every dimension of what it means to produce a safe, effective medical device that a surgeon can trust in the most critical moment of a patient's care.

Certification is ongoing, not static. We maintain an active post-market surveillance program and conduct regular internal and external audits to maintain compliance at all times.

ISO 13485:2016

Medical Device Quality Management

Certified

CDSCO Compliant

Central Drugs Standard Control Organization

Certified

CE Marking

European Union Compliance

In Progress

Target: 2026

MDSAP

Medical Device Single Audit Program

In Progress

Target: 2026